Advanced search
Publication Cover
Pathogens and Global Health Volume 116, 2022 - Issue 7
Submit an article Journal homepage
167
Views
3
CrossRef citations to date
0
Altmetric
Commentary

Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand

Nasamon Wanlapakorna Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Nungruthai Suntronwonga Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Sitthichai Kanokudoma Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Suvichada Assawakosria Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Pornjarim Nilyanimita Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Ritthideach Yorsaenga Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Jira Chansaenroja Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
&
Yong Poovorawana Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;b FRS(T), the Royal Society of Thailand, Sanam Sueapa, Dusit, Bangkok, ThailandCorrespondence[email protected]
View further author information
 show all
Pages 395-397 | Published online: 03 Aug 2022

References

  • Wanlapakorn N, Suntronwong N, and Phowatthanasathian H, et al. Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: real-world data. Vaccine. 2022;40(23):3203–3209.
  • Assawakosri S, Kanokudom S, Suntronwong N, et al. Neutralizing activities against the omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination. J Infect Dis. 2022:jiac092. DOI:10.1093/infdis/jiac092.
  • Chansaenroj J, Suntronwong N, and Kanokudom S, et al. Immunogenicity following two doses of the BBIBP-CorV vaccine and a third booster dose with a viral vector and mRNA COVID-19 vaccines against delta and omicron variants in prime immunized adults with two doses of the BBIBP-CorV vaccine. Vaccines (Basel). 2022;10(7):1071.
  • Assawakosri S, Kanokudom S, Chansaenroj J, et al. Persistence of immunity against omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination. Int J Infect Dis. 2022. DOI:10.1016/j.ijid.2022.07.038.
  • Suntronwong N, Kanokudom S, Auphimai C, et al. Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination. medRxiv. 2022. DOI:10.1101/2022.04.25.22274294.
  • Jara A, Undurraga EA, Zubizarreta JR, et al. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study. Lancet Glob Health. 2022;10(6):e798–e806.
  • Accorsi EK, Britton A, Fleming-Dutra KE, et al. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and delta variants. JAMA. 2022;327(7):639–651.
  • Andrews N, Stowe J, Kirsebom F, et al. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. 2022;28(4):831–837.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.